Investors Business Daily
06 Feb 2026, 19:01 UTC · 36w ago
Impact · against what's priced in
The news provides moderately bullish catalysts for Aurinia Pharmaceuticals and Berkshire Hathaway, though the magnitude for AUPH is tempered by the speculative nature of management overhauls. Arista Networks' beat is positive but expected given its status as an analyst favorite for growth.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish
Berkshire Hathaway beat earnings expectations and has ended a 14-quarter streak of selling equities.
More positive than 94% of claims this week
Aurinia Pharmaceuticals (AUPH) announced a complete overhaul of its C-suite executive team.
Continue reading
5 related stories
Berkshire Hathaway's decision to end a 14-quarter streak of selling equities signals a significant shift in risk appetite and capital allocation.
Read from the article alone
No priced-in read yet
A complete overhaul of the C-suite and a bullish chart pattern provide speculative catalysts for an operational turnaround.
Read from the article alone
No priced-in read yet
Arista Networks beat earnings views, aligning with its position as a top pick for earnings growth.
Read from the article alone
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 68% of claims this week
The Dow and S&P 500 have reached new highs.
More positive than 55% of claims this week
Which stocks this story touches
More positive than 90% of ticker scores this week
The company beat earnings expectations and ended a long streak of selling equities.
More positive than 84% of ticker scores this week
The company beat earnings views and is listed as an analyst favorite for earnings growth.
More positive than 78% of ticker scores this week
The stock is forming a bullish chart pattern and has undergone a C-suite overhaul sparking hope.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
1h ago
—
No price for BRK.B right now — the quote feed didn't answer.
BRK.B chart →+18.5%
Price agrees with the score
$16.90 vs $14.26 close before publication (Feb 5) · not market-adjusted
AUPH chart →+43.3%
Price agrees with the score
$184.33 vs $128.67 close before publication (Feb 5) · not market-adjusted
ANET chart →
